Medibios Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 7.10 Cr
as on 05-07-2024
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 24.96 Cr
as on 05-07-2024
- Satisfied Charges ₹ 39.29 Cr
as on 05-07-2024
- Revenue 6.75%
(FY 2022)
- Profit -4.05%
(FY 2022)
- Ebitda 20.24%
(FY 2022)
- Net Worth 23.36%
(FY 2022)
- Total Assets 17.63%
(FY 2022)
About Medibios Laboratories
The Corporate was formerly known as Medibios Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.10 Cr.
The company currently has active open charges totaling ₹24.96 Cr. The company has closed loans amounting to ₹39.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Medibios Laboratories Limited India is Sangeeta Dhanuka as COMPANY SECRETARY. Sharad Sheth, Meena Kapadi, Yogesh Gole, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1995PLC086180
- Company No.
086180
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Mar 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medibios Laboratories Limited offer?
Medibios Laboratories Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets, Doxycycline Tablet.
Who are the key members and board of directors at Medibios Laboratories?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tushar Korday  | Managing Director | 14-May-2010 | Current |
| Sangeeta Dhanuka | Company Secretary | 20-Mar-2018 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharad Sheth | Director | 20-Mar-2018 | Current |
| Meena Kapadi | Director | 20-Mar-2018 | Current |
| Yogesh Gole | Director | 01-Nov-2011 | Current |
| Rajendra Gole | Whole-Time Director | 25-Feb-2004 | Current |
Financial Performance and Corporate Structure Insights of Medibios Laboratories.
Medibios Laboratories Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.75% increase. The company also saw a slight decrease in profitability, with a 4.05% decrease in profit. The company's net worth Soared by an impressive increase of 23.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medibios Laboratories?
In 2021, Medibios Laboratories had a promoter holding of 99.70% and a public holding of 0.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Emil Pharmaceutical Industries Pvt LtdActive 38 years 7 monthsRajendra Gole and Tushar Korday are mutual person
- Emil Holdings Private LimitedActive 29 years 4 months
Rajendra Gole and Tushar Korday are mutual person
Prime Property Development Corporation LimitedActive 31 years 11 monthsMeena Kapadi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Sep 2020 | ₹2.22 Cr | Open |
Others Creation Date: 05 Aug 2016 | ₹22.74 Cr | Open |
Axis Bank Limited Creation Date: 26 Jun 2018 | ₹17.00 Cr | Satisfied |
How Many Employees Work at Medibios Laboratories?
Medibios Laboratories has a workforce of 138 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medibios Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medibios Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
